WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke ADAPT wurde als Wortmarke am 03.02.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1677688 |
| Länder | 
|
| Basismarke |
Nr. 90867247,
05. August 2021
|
| Anmeldedatum | 03. Februar 2022 |
| Ablaufdatum | 03. Februar 2032 |
Markeninhaber
11099 North Torrey Pines Road,
Suite 160
US
Suite 160
US
Markenvertreter
425 MARKET STREET
SAN FRANCISCO CA 94105
US
Waren und Dienstleistungen
05
Pharmaceutical products, preparations, and substances for
the prevention and treatment of cancer, infectious diseases,
allergies, mental illnesses, chemotherapy side effects,
radiation side effects, transplantation side effects, and
viral, metabolic, cardiovascular, vascular, pulmonary,
blood, dermatologic, fibrotic, autoimmune, inflammatory,
neurodegenerative, neuromuscular, dietary deficiency,
hereditary, endocrine, eye, ear, and voice related diseases
and disorders; biological products, preparations, and
substances for the prevention and treatment of cancer,
infectious diseases, allergies, mental illnesses,
chemotherapy side effects, radiation side effects,
transplantation side effects, and viral, metabolic,
cardiovascular, vascular, pulmonary, blood, dermatologic,
fibrotic, autoimmune, inflammatory, neurodegenerative,
neuromuscular, dietary deficiency, hereditary, endocrine,
eye, ear, and voice related diseases and disorders;
immunotherapies for the prevention and treatment of cancer,
infectious diseases, allergies, mental illnesses,
chemotherapy side effects, radiation side effects,
transplantation side effects, and viral, metabolic,
cardiovascular, vascular, pulmonary, blood, dermatologic,
fibrotic, autoimmune, inflammatory, neurodegenerative,
neuromuscular, dietary deficiency, hereditary, endocrine,
eye, ear, and voice related diseases and disorders (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations); vaccines; biotechnology
platform technology, namely, viral and vaccine vectors for
delivery and insertion of function-altering genetic material
into human and animal patients, plants, and crops, for
visualization of specific cell types, for inducing humoral
and cell-mediated responses, for targeting and killing
cancer cells, for removing pathological functions, for
controlling biological pests, and for boosting crop yields
(term considered too vague by the International Bureau -
Rule 13 (2) (b) of the Regulations)
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 16. Juni 2023 | 2023/25 Gaz | EM | Ablehnung |
| 01. Juni 2023 | 2023/22 Gaz | JP | Ablehnung |
| 04. Januar 2023 | 2023/1 Gaz | GB | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 23. September 2022 | 2022/42 Gaz | RAW: Limitation | |
| 12. September 2022 | 2022/38 Gaz | EM | Ablehnung |
| 26. August 2022 | 2022/35 Gaz | GB | Ablehnung |
| 03. Februar 2022 | 2022/30 Gaz | US | Eintragung |
ID: 141677688